Segment Information

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Segment Information

Segment Information

The Company has identified two operating segments, diagnostic services and consumer products, based on the manner in which the Company’s CEO as CODM assesses performance and allocates resources across the organization. The operating segments are organized in a manner that depicts the difference in revenue generating synergies that include the separate processes, profit generation and growth of each segment. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services. The unallocated corporate expenses mainly included professional fees, interest expenses associated with the outstanding debt associated with the Company.

The following table is a summary of segment information for Fiscal 2024 and 2023 (in thousands):

	For the years ended
	December 31, 2024		December 31, 2023
Net revenues
Diagnostic services	$	—	$	24,849
Consumer products	6,770		10,135
Consolidated net revenue	6,770		34,984
Cost of revenue
Diagnostic services	2,329		11,790
Consumer products	4,591		7,638
Consolidated cost of revenue	6,920		19,428
Depreciation and amortization expense
Diagnostic services	1,604		2,618
Consumer products	4,583		3,432
Total Depreciation and amortization expense	6,187		6,050
Operating and other expenses
Diagnostic services	15,928		12,245
Consumer products	4,484		7,533
Unallocated corporate	15,581		12,126
Total operating and other expenses	35,993		31,904
Loss from operations, before income taxes
Diagnostic services	(19,861)		(1,804)
Consumer products	(6,888)		(8,468)
Unallocated corporate	(15,581)		(12,126)
Total loss from operations, before income taxes	(42,330)		(22,398)
Income tax (expense) benefit	(7,195)		6,018
Net loss from continuing operations	$	(49,525)	$	(16,380)

The following table is a summary of segment information for Fiscal 2024 and Fiscal 2023 (in thousands):

	December 31, 2024		December 31, 2023
ASSETS
Diagnostic services	$	26,069	$	44,221
Consumer products	19,745		23,284
Unallocated corporate	5,804		19,065
Assets held-for-sale	11,582		5,357
Total assets	$	63,200	$	91,927